ABBOTT ID NOW™ COVID-19
SARS-CoV-2 in 13 minutes or less*
The ID NOW™ platform combines the benefits of speed and accuracy for the fastest molecular results in the market.
The ID NOW™ COVID-19 test returns positive results in 13 minutes or less to enable immediate clinical decisions during the first patient visit.
The easy to use ID NOW™ platform is designed for near-patient, point-of-care use in a variety of healthcare settings.*
Product not available in all countries.
SPEED – Faster treatment decisions
The ID NOW™ COVID-19 assay returns results in 13 minutes or less, to enable immediate clinical decisions during the first patient visit.
TECHNOLOGY – Molecular performance
Proven isothermal molecular technology provides the fastest molecular results in the market.
EASE OF USE
- Intuitive, CLIA-waived test procedure is designed for near-patient, point-of-care testing.
- Assay kit contains necessary testing components (24 tests, patient swabs and positive control swab) and can be stored at room temperature.
- Direct sample types include: nasal swab, nasopharyngeal swab and throat swabs